# Early Implementation of the Navigator-Assisted Hypofractionation (NAVAH) Program in Hispanic-American Breast Cancer Patients

## TL;DR

This paper introduces a program to improve cancer care for Hispanic-American breast cancer patients by addressing treatment barriers.

## Contribution

The paper presents the early implementation of the NAVAH program tailored for Hispanic-American breast cancer patients.

## Key findings

- Hispanic populations in the US have higher cancer mortality rates compared to other groups.
- The NAVAH program is being implemented to address barriers in cancer care for this population.
- Hispanic population growth highlights the urgency of improving cancer care delivery for this group.

## Abstract

Although cancer-related mortality in the United States (US) has generally been decreasing, this has not occurred among Hispanic populations, where cancer is the leading cause of death. The population growth of the Hispanic population in the US from 2010 to 2021 was substantially larger than the overall US population growth rate (24% vs. 7%). This increased population growth adds importance to addressing cancer care delivery barriers facing this patient population. We discuss early implementation of the Navigator-Assisted Hypofractionation (NAVAH) program in addressing these barriers.